Marshall Wace’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
BIP
Marshall Wace's PBH Position: Q2 2026 in Review
Marshall Wace reduced its Prestige Consumer Healthcare (PBH) stake by 44% in Q2 2026, selling an estimated $1.25M and leaving 31,011 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2015.
Marshall Wace first reported a position in PBH in Q2 2014 and has held it in 15 quarters since. The position peaked at $8.53M in Q2 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Marshall Wace held 31,011 shares of Prestige Consumer Healthcare worth $1.47M as of Q2 2026.
- Marshall Wace sold 24,241 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.25M.
- Prestige Consumer Healthcare made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2015 holding.
- Marshall Wace first reported a position in Prestige Consumer Healthcare in Q2 2014 and has held it in 15 quarters since.
- Marshall Wace's Prestige Consumer Healthcare position peaked at $8.53M in Q2 2024.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.